After large pharmacuetical factories dedicated to manufacturing proteins sprang up in Singapore, South Korea and China, Taiwan's government looked into this issue last year, contacting Chang's company in hopes of marshaling Tanox's successful experience to spur domestic biotech drug manufacturing.
在新加坡、韓國、中國紛紛創建生產蛋白質的大型藥廠後，去年政府也曾研擬跟進，與張子文的 Tanox 公司接洽，希望能借重 Tanox 公司的成功經驗而帶動國內的生技製藥能力。